|
|
|
|
Conference:
Pre-conference briefing
16 Sept 8am - 5:30pm
Day 1
17 Sept 8am - 5:30pm
Day 2
18 Sept 8am - 5:30pm
Post-conference workshop
19 Sept 8am - 5:30pm
› Email a friend
› Add this to my calendar
|
 |
|
|
|
bioLOGIC Europe: a proven track record
“Excellent platform for networking and information exchange on latest stage of science based manufacturing, regulatory and business issues”
Rolf Werner, Corporate Director, Corporate Division Biopharmaceuticals, Boehringer Ingelheim
|
The pharmaceutical industry is facing challenging times. An aging portfolio of blockbuster drugs is approaching the end of patent protection. The cost of R&D is rising. The number of new ‘small molecule’ drugs being approved continues to fall. The major players are actively looking elsewhere to fill product pipelines and meet growth targets…
Listen to over 60 of the World’s leading strategic and scientific experts at the 9th annual bioLOGIC Europe conference and understand why more and more large pharmaceutical and biotech companies are focusing their attention on biologics. Learn from the experiences of flourishing, innovative biotech business leaders in an environment where only the very best achieve success.
» Book your place today
» View full conference programme
Who will attend?
- Pharmaceutical manufacturers
- Established and start-up biotechs
- Regional development agencies
- Government and regulatory bodies
- Research institutes
- CMOs
- CROs
- Consultants
- Venture capitalists
» Download the conference brochure
|
This year's speakers include:
» View full speaker's list
|
 Some of the reason you need to attend :
-
Hear from the pharmaceutical industry’s foremost thinkers in our keynote session on what the future really holds for biologics, the wider pharmaceutical industry, and what this means for your business.
-
Listen to regulator and industry perspectives on the latest regulatory developments and discover what’s around the corner both in Europe, at the FDA and further a field.
-
Contribute to the discussion on the future for biosimilars with our expertly assembled speaker and panel session.
-
Benefit from the choice of two dedicated streams:
- Strategic stream focusing on regulatory developments, pipeline development strategies, biosimilars, pricing, new fields and technologies.
- Technical stream focusing on product development, comparability, immunogenicity and Quality by Design.
-
Gain a valuable insight into how the World’s leading pharmaceutical and biotech companies are addressing the issues that matter.
|
|
|
Conference:
Pre-conference briefing
16 Sept 8am - 5:30pm
Day 1
17 Sept 8am - 5:30pm
Day 2
18 Sept 8am - 5:30pm
Post-conference workshop
19 Sept 8am - 5:30pm
› Email a friend
› Add this to my calendar
|
|
|
|
|
|
|
|
|
|
Dr Christian Rohlff CEO
Giampierro De Luca Senior Executive and VP, Licensing and Intellectual Property Merck Serono
Dr Louis-Christian Clauss
Dr Patrick Vink
Dr Michael 
